[go: up one dir, main page]

WO2013180730A1 - Large-scale high yield manufacturing process for high purity pentaalkyl esters of dtpa - Google Patents

Large-scale high yield manufacturing process for high purity pentaalkyl esters of dtpa Download PDF

Info

Publication number
WO2013180730A1
WO2013180730A1 PCT/US2012/040347 US2012040347W WO2013180730A1 WO 2013180730 A1 WO2013180730 A1 WO 2013180730A1 US 2012040347 W US2012040347 W US 2012040347W WO 2013180730 A1 WO2013180730 A1 WO 2013180730A1
Authority
WO
WIPO (PCT)
Prior art keywords
dtpa
diethylenetriaminepentaacetic acid
formula
pentaalkyl
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/040347
Other languages
French (fr)
Inventor
Lowell Jeffry LAWRENCE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/US2012/040347 priority Critical patent/WO2013180730A1/en
Publication of WO2013180730A1 publication Critical patent/WO2013180730A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters

Definitions

  • the present invention relates to the development of a large-scale manufacturing process applicable to the preparation of pentaalkyl esters of diethylenetriaminepentaacetic acid (hereinafter referred to as DTPA) of formula (I), and more particularly the pentaethyl ester of diethylenetriaminepentaacetic acid (hereinafter referred to as C2E5) of formula (II).
  • DTPA pentaalkyl esters of diethylenetriaminepentaacetic acid
  • C2E5 pentaethyl ester of diethylenetriaminepentaacetic acid
  • DTPA of formula (III) is a ligand widely used for the clathration of metal ions
  • DTPA transuranic radionuclides
  • the calcium and zinc salts of DTPA are both approved by the Food and Drug Administration for the removal (decorporation) of transuranic radionuclides such as Plutonium, Americium and Curium from the body of humans following contamination by these highly toxic elements.
  • DTPA is a highly polar compound and therefore must be administered intravenously in order to enter the bloodstream and remove the contaminating radionuclides, which are eliminated in the urine and feces following chelation by DTPA.
  • the document describes a new commercially viable, safe and industrially suitable process for the preparation of pentaalkyl esters of diethylenetriaminepentaacetic acid of formula (I), and the pentaethyl ester of diethylenetriaminepentaacetic acid of formula (II) by using concentrated hydrochloric acid (Cone. HCl) instead of concentrated sulfuric acid (Cone. H 2 SO 4 ) as an acid for the esterifaction of DTPA of the formula (III).
  • the pentaalkyl or pentaethyl ester product is extracted with ethyl acetate (EtOAc) instead of dichloromethane (DCM), and then washed with aq.
  • an acid used for the esterification of DTPA is selected from both Bronstead acids, but more particularly, Concentrated Hydrochloric acid (Cone. HC1).
  • concentrated hydrochloric acid has a molar concentration of greater than about 12M.
  • the alcohol used is not particularly restricted. A lower molecular weight alcohol is preferably used, more particularly methanol, ethanol, propanol, iso-propanol and the like, and most preferably ethanol. The alcohol must be used in excess and there is no need to use other solvents in the esterification reaction.
  • the esterification reaction temperature may preferably be at reflux temperature of the alcohol employed.
  • a preferred reaction time may be from 1 to 48 hours depending on the volume of the reaction being performed.
  • the crude product is extracted with a suitable solvent selected from methylacetate, ethyl acetate, propylacetate, benzene, toluene, xylene, diethyl ether, diisopropyl ether, t-butyl methyl ether and other non-halogenated organic solvents, and the like mixtures thereof, but more particularly ethyl acetate (EtOAc).
  • EtOAc ethyl acetate
  • the resulting organic layer is washed with aq. Alkaline solution selected from aq. Potassium bicarbonate (aq.
  • KHCO 3 aq. Potassium carbonate
  • aq. K 2 CO 3 aq. Sodium bicarbonate
  • aq. Na 2 C0 3 aq. Sodium Carbonate
  • other mild inorganic bases but more particularly aq. Potassium bicarbonate (aq. KHCO 3 ) solution.
  • DTPA 20 kg was added to a mixture of alcohol (500 L) and concentrated hydrochloric acid (32% w/v, 6.8 kg) at 20-25°C.
  • the reaction mixture was slowly heated to reflux temperature of the alcohol and maintained for 48 hours at reflux temperature.
  • the progress of the reaction was monitored on thin layer chromatography (TLC).
  • TLC thin layer chromatography
  • the reaction mixture is concentrated under vacuum distillation at 60-65 °C to remove ethanol, water, hydrochloric acid, and other volatiles to give a thick glassy oil.
  • the obtained residue was dissolved in ethyl acetate (80 L).
  • the resultant solution was washed 4 times with saturated aq. Potassium bicarbonate solution (saturated aq.
  • DTPA 20 Kg was added to a mixture of ethanol (500 L) and concentrated hydrochloric acid (32% w/v, 6.8 kg) at 20-25°C.
  • the reaction mixture was slowly heated to 76°C and maintained for 48 hours at 76-78°C.
  • the progress of the reaction was monitored using thin layer chromatography (TLC).
  • TLC thin layer chromatography
  • the reaction mixture was concentrated under vacuum distillation at 60-65°C to remove ethanol, water, hydrochloric acid, and other volatile components to give a thick glassy oil.
  • the residue was dissolved in ethyl acetate (80 L). The resulting solution was washed 4 times with saturated aq. Potassium bicarbonate solution (saturated aq.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

LARGE-SCALE, HIGH YIELD MANUFACTURING PROCESS FOR HIGH PURITY
PENTAALKYL ESTERS OF DTPA
FIELD OF THE INVENTION
[0001] The present invention relates to the development of a large-scale manufacturing process applicable to the preparation of pentaalkyl esters of diethylenetriaminepentaacetic acid (hereinafter referred to as DTPA) of formula (I), and more particularly the pentaethyl ester of diethylenetriaminepentaacetic acid (hereinafter referred to as C2E5) of formula (II).
Figure imgf000002_0001
BACKGROUND OF THE INVENTION
[0002] DTPA of formula (III) is a ligand widely used for the clathration of metal ions
(Wenzel, T. J., Bogyo, M.S. and Lebeau, E. L.; J. Am. Chern. Soc; 1994; 116; 4858). The calcium and zinc salts of DTPA are both approved by the Food and Drug Administration for the removal (decorporation) of transuranic radionuclides such as Plutonium, Americium and Curium from the body of humans following contamination by these highly toxic elements. However, DTPA is a highly polar compound and therefore must be administered intravenously in order to enter the bloodstream and remove the contaminating radionuclides, which are eliminated in the urine and feces following chelation by DTPA. Given the increasing possibility of a mass contamination event (such as the terroristic detonation of a "dirty bomb" or the contamination of a municipal water supply with these radioactive elements), the United States government has been seeking a means to treat large numbers of poisoned individuals with this decorporation agent. Such a scenario would require a form of the drug that could easily be distributed to large numbers of individuals and could be taken orally and facilitate efficient absorption of the compound into the blood stream from the gastrointestinal tract. The compound, pentaethyl ester of diethylenetriaminepentaacetic acid (C2E5) of formula (II) was reported as a useful ligand for the decorporation of radioactive compounds following oral administration to mammals (US Patent No. 8,030,358).
[0003] Several methods for the synthetic preparation of pentaalkyl esters of diethylenetriaminepentaacetic acid of formula (I), or the pentaethyl ester of diethylenetriaminepentaacetic acid (C2E5) of formula (II) have already been described and/or patented (US Patent No. 8,030,358 to Jay et al.; US Patent No. 5,780,670 to Yamamato, et al.; Nemoto, et al.; 1995 International Chemical Congress of Pacific Basin Societies; December 17-22, 1995), but all of these methods have been applied to very small (mg to gm) quantities and all incorporate the use of silica gel chromatography to obtain the final product in a pure form. They also are performed in dichloromethane, which is a hazardous chlorinated solvent and they further teach the final wash with sodium hydroxide which partially hydrolyzes the fully esterified product, hence reducing the yield and the purity of the product. An example of the currently used process is given below as detailed in US Patent No. 5,780,670 referenced above.
Figure imgf000003_0001
Figure imgf000003_0002
Scheme 1
[0004] Though this process is satisfactory for the preparation of very small quantities of the various esters, it cannot be scaled up to any significant quantities and also presents the following additional disadvantages. [0005] 1) The use and handling of a highly volatile halogenated solvent i.e., dichloromethane (DCM) to extract the final product. Dichloromethane vapors are toxic and possibly carcinogenic. It should also be noted that DCM is denser than the aqueous layer and therefore comprises the bottom layer in a reaction vessel. To obtain the product from a bottom layer on a large-scale process is extremely cumbersome and labor-intensive.
[0006] 2) The use of aq. NaOH solution to remove acidic impurities is likely to hydrolyze the ester product resulting in a decrease in the yield and final purity of the product.
[0007] 3) Finally, the purification of the product by column chromatography cannot possibly be performed on a large scale.
[0008] To overcome the above problems, there exists a need to develop a commercially viable, scalable, operationally simple, safe and eco-friendly process for the synthesis of pentaalkyl esters of diethylenetriaminepentaacetic acid of formula (I), and particularly the pentaethyl ester of diethylenetriaminepentaacetic acid of formula (II).
[0009] The document describes a new commercially viable, safe and industrially suitable process for the preparation of pentaalkyl esters of diethylenetriaminepentaacetic acid of formula (I), and the pentaethyl ester of diethylenetriaminepentaacetic acid of formula (II) by using concentrated hydrochloric acid (Cone. HCl) instead of concentrated sulfuric acid (Cone. H2SO4) as an acid for the esterifaction of DTPA of the formula (III). The pentaalkyl or pentaethyl ester product is extracted with ethyl acetate (EtOAc) instead of dichloromethane (DCM), and then washed with aq. Potassium bicarbonate (aq. KHCO3) solution instead of aq. Sodium hydroxide (aq. NaOH) solution to remove acidic impurities. Finally, the organic layer (which forms as the top layer of the reaction mixture is subjected to vacuum distillation at 65-70°C under 20 torr pressure to remove EtOAc and other volatiles to yield the pure product as a pale yellow oil. This process is devoid of the above described disadvantages and avoids the use of column purification to produce the pure product.
DETAILED DESCRIPTION OF THE INVENTION
[0010] The syntheses of pentaalkyl esters of diethylenetriaminepentaacetic acid of formula (I), and the pentaethyl ester of diethylenetriaminepentaacetic acid of formula (II) are shown in Scheme 2:
Figure imgf000005_0001
ίΊ> Π'Λ. Πϋ
Figure imgf000005_0002
Scheme 2
[0011] In one embodiment, an acid used for the esterification of DTPA is selected from both Bronstead acids, but more particularly, Concentrated Hydrochloric acid (Cone. HC1). For purposes of this document, concentrated hydrochloric acid has a molar concentration of greater than about 12M. The alcohol used is not particularly restricted. A lower molecular weight alcohol is preferably used, more particularly methanol, ethanol, propanol, iso-propanol and the like, and most preferably ethanol. The alcohol must be used in excess and there is no need to use other solvents in the esterification reaction.
[0012] In another embodiment, the esterification reaction temperature may preferably be at reflux temperature of the alcohol employed. A preferred reaction time may be from 1 to 48 hours depending on the volume of the reaction being performed.
[0013] In yet another embodiment, after completion of the esterification reaction, the crude product is extracted with a suitable solvent selected from methylacetate, ethyl acetate, propylacetate, benzene, toluene, xylene, diethyl ether, diisopropyl ether, t-butyl methyl ether and other non-halogenated organic solvents, and the like mixtures thereof, but more particularly ethyl acetate (EtOAc). [0014] In still another embodiment, after completion of the esterification reaction and extraction of the crude product, the resulting organic layer is washed with aq. Alkaline solution selected from aq. Potassium bicarbonate (aq. KHCO3), aq. Potassium carbonate (aq. K2CO3), aq. Sodium bicarbonate (aq. NaHCC^), aq. Sodium Carbonate (aq. Na2C03), and other mild inorganic bases, but more particularly aq. Potassium bicarbonate (aq. KHCO3) solution.
[0015] The present embodiments are illustrated with the following examples, which should not be construed as limiting in scope.
Example-1
[0016] Preparation of pentaalkyl esters of diethylenetriaminepentaacetic acid (I):
DTPA (20 kg) was added to a mixture of alcohol (500 L) and concentrated hydrochloric acid (32% w/v, 6.8 kg) at 20-25°C. The reaction mixture was slowly heated to reflux temperature of the alcohol and maintained for 48 hours at reflux temperature. The progress of the reaction was monitored on thin layer chromatography (TLC). After completion of the reaction, the reaction mixture is concentrated under vacuum distillation at 60-65 °C to remove ethanol, water, hydrochloric acid, and other volatiles to give a thick glassy oil. The obtained residue was dissolved in ethyl acetate (80 L). The resultant solution was washed 4 times with saturated aq. Potassium bicarbonate solution (saturated aq. KHCO3, 10 lit x 4) to remove un-reacted DTPA and other process related acidic substances. The organic layer was concentrated by distillation at 20 torr pressure at 65-70°C to remove ethyl acetate and other volatile compounds to afford pentaalkyl esters of diethylenetriaminepentaacetic acid. The products are cooled to 40-60°C and filtered to give pure pentaalkyl esters of diethylenetriaminepentaacetic acid (20-25 Kg).
Example-2
[0017] Preparation of pentaethyl ester of diethylenetriaminepentaacetic acid (II):
DTPA (20 Kg) was added to a mixture of ethanol (500 L) and concentrated hydrochloric acid (32% w/v, 6.8 kg) at 20-25°C. The reaction mixture was slowly heated to 76°C and maintained for 48 hours at 76-78°C. The progress of the reaction was monitored using thin layer chromatography (TLC). After completion of the reaction, the reaction mixture was concentrated under vacuum distillation at 60-65°C to remove ethanol, water, hydrochloric acid, and other volatile components to give a thick glassy oil. The residue was dissolved in ethyl acetate (80 L). The resulting solution was washed 4 times with saturated aq. Potassium bicarbonate solution (saturated aq. KHCO3, 10 lit x 4) to remove unreacted DTPA and other process related acidic substances. The organic layer was concentrated by distillation at 20 torr pressure and 65-70°C to remove ethyl acetate and other volatiles to yield the pentaethyl ester of diethylenetriaminepentaacetic acid (C2E5) as a pale yellow oil. The product was cooled to 40-60°C and filtered to give highly pure pentaethyl ester of diethylenetriaminepentaacetic acid (C2E5) as a pale yellow oil at a high yield (20 Kg).

Claims

WHAT IS CLAIMED:
1. A process of preparation of pentaalkyl ester of diethylenetriaminepentaacetic acid of formula (1), and pentaethyl ester of diethylenetriaminepentaacetic acid of formula (II)
Figure imgf000008_0001
comprising steps of:
(i) esterifying diethylenetriaminepentaacetic acid (DTPA, III):
Figure imgf000008_0002
(DTPA, 111) with a an alcohol in the presence of a Bronstead acid, at a reflux temperature of said alcohol to give crude pentaalkyl esters of DTPA;
(ii) extracting said crude pentaalkylesters of DTPA with a solvent selected from a group consisting of methyl acetate, ethyl acetate, propyl acetate, benzene, toluene, xylene, diethyl ether, diisopropyl ether, t-butyl methyl ether, other non-halogenated organic solvents, and mixtures thereof and recovering a resulting organic layer;
(iii) washing said resulting organic layer with aq. alkaline solution to remove un-reacted DTPA and other process related acidic substances;
(iv) concentrating and filtering the resulting organic layer to obtain said pentaalkyl ester of diethylenetriaminepentaacetic acid of formula (I), or pentaethyl ester of
diethylenetriaminepentaacetic acid of formula (II).
2. The process of claim 1 wherein said Bronstead acid is concentrated hydrochloric acid having a molar concentration of greater than about 12M.
3. The process of claim 1, wherein said alcohol is a low molecular weight alcohol selected from a group consisting of methanol, ethanol, propanol, isopropanol and mixtures thereof.
4. The process of claim 1 , wherein said alcohol is ethanol.
5. The process of claim 1, wherein said alkaline solution is selected from a group consisting of aqueous potassium bicarbonate (KHCO3), aqueous potassium carbonate (K2CO3), aqueous sodium bicarbonate (NaHCC^), aqueous sodium carbonate (Na2CC>3) and mixtures thereof.
6. The process of claim 1 , wherein said alkaline solution is aqueous potassium bicarbonate (KHCO3).
7. The process of claim 1, wherein said solvent is selected from a group consisting of methyl acetate, ethyl acetate, propyl acetate, benzene, toluene, xylene, diethyl ether, diisopropyl ether, t-butyl methyl ether, a non-hydrogenated organic solvent and mixtures thereof.
8. The process of claim 1, wherein said solvent is ethyl acetate.
9. The process of claim 1, wherein said alcohol is ethanol, said Bronstead acid is hydrochloric acid, said solvent is ethyl acetate and said alkaline solution is aqueous potassium bicarbonate (KHCO3).
10. The process of claim 1 wherein said concentrating is completed under vacuum distillation.
11. A process of preparation of pentaalkyl ester of diethylenetriaminepentaacetic acid of formula (I) and pentaethyl ester of diethylenetriaminepentaacetic acid of formula (II);
R
Figure imgf000010_0001
comprising steps of:
(i) esterifying diethylenetriaminepentaacetic acid (DTPA, III) to give crude pentaalkyl esters of DTPA;
Figure imgf000010_0002
(ii) extracting said crude pentaalkyl esters of DTPA with a non-halogenated organic solvent and recovering a resulting organic layer;
(iii) washing said resulting organic layer with an alkaline solution;
(iv) concentrating said resulting organic layer after washing followed by filtration to obtain said pentaalkyl ester of diethylenetriaminepentaacetic acid of formula (I) and pentaethyl ester of diethylenetriaminepentaacetic acid of formula (II).
PCT/US2012/040347 2012-06-01 2012-06-01 Large-scale high yield manufacturing process for high purity pentaalkyl esters of dtpa Ceased WO2013180730A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US2012/040347 WO2013180730A1 (en) 2012-06-01 2012-06-01 Large-scale high yield manufacturing process for high purity pentaalkyl esters of dtpa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/040347 WO2013180730A1 (en) 2012-06-01 2012-06-01 Large-scale high yield manufacturing process for high purity pentaalkyl esters of dtpa

Publications (1)

Publication Number Publication Date
WO2013180730A1 true WO2013180730A1 (en) 2013-12-05

Family

ID=49673775

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/040347 Ceased WO2013180730A1 (en) 2012-06-01 2012-06-01 Large-scale high yield manufacturing process for high purity pentaalkyl esters of dtpa

Country Status (1)

Country Link
WO (1) WO2013180730A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5780670A (en) * 1995-07-21 1998-07-14 Tohoku University DTPA derivatives modified with non-ester bond and a process for synthesizing them
US7279149B2 (en) * 2003-10-29 2007-10-09 Mayo Foundation For Medical Education And Research Amino acid composition with increased blood brain barrier permeability
US8030358B2 (en) * 2007-10-29 2011-10-04 University Of Kentucky Research Foundation Methods and pharmaceutical compositions for decorporation of radioactive compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5780670A (en) * 1995-07-21 1998-07-14 Tohoku University DTPA derivatives modified with non-ester bond and a process for synthesizing them
US7279149B2 (en) * 2003-10-29 2007-10-09 Mayo Foundation For Medical Education And Research Amino acid composition with increased blood brain barrier permeability
US8030358B2 (en) * 2007-10-29 2011-10-04 University Of Kentucky Research Foundation Methods and pharmaceutical compositions for decorporation of radioactive compounds

Similar Documents

Publication Publication Date Title
DK2435439T3 (en) PREPARATION OF nalmefene HYDROCHLORIDE FROM naltrexone
JP6055183B2 (en) Nalmefene hydrochloride dihydrate
JP5988272B2 (en) Oxycodone synthesis and purification process
PL168847B1 (en) The method of obtaining diacetylrhein PL PL PL
RU2260582C2 (en) Method for purifying pravastatin
EA024688B1 (en) Process for the preparation of sitagliptin and its pharmaceutically acceptable salts
US10538507B2 (en) Preparation process for high-purity dabigatran etexilate
ES2622156T3 (en) Procedure for the recovery of nalmefene hydrochloride
TW200846354A (en) Trityl chloride recovery
WO2013180730A1 (en) Large-scale high yield manufacturing process for high purity pentaalkyl esters of dtpa
HRP20030438A2 (en) A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
RU2712232C1 (en) Improved method of producing nalmefene from naltrexone
CN102633796B (en) New preparation method of sophora flavescens acid derivative
WO2006099635A1 (en) Isolation of galanthamine from biological material
EP4215540A1 (en) Method for mass-producing sodium taurodeoxycholate
KR100881890B1 (en) Method for preparing safogrelate hydrochloride
NO312831B1 (en) Process for the preparation of 3-amine-1,2-propanediol
CN102030674A (en) Method for preparing intermediate of cilastatin
WO2011004281A1 (en) A process for the preparation of amorphous form of rabeprazole sodium
US20250026708A1 (en) Process for preparation of triheptanoin
KANEKO Palladium Dehydrogenation of Methyl Reserpate and Yohimbine in Cymene1
Clowes VARIETIES.
CN1966485A (en) Method for synthesizing shikimic acid derivative
JP2004002447A (en) Industrially produced composition containing pravastatin sodium
JPH03294273A (en) Tristilbene compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12877944

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12877944

Country of ref document: EP

Kind code of ref document: A1